TAGLIAFERRI MARY — SEC Form 4 filings

SEC reporting owner CIK 1323304. 4 Form 4 filings on record with FilingPulse; latest filed 2024-06-13.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-02 to 2024-06-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Y-mAbs Therapeutics, Inc. (YMAB)Director24
RayzeBio, Inc. (RYZB)Director12
ENZO BIOCHEM INC (ENZ)Director11

Form 4 filings — TAGLIAFERRI MARY

FiledFormIssuerReported transactionsSource
2024-06-134Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 3,495 @ $0 · Grant/award (A): 14,545 (derivative) @ $0EDGAR
2024-03-144Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 4,660 @ $0 · Grant/award (A): 27,900 (derivative) @ $0EDGAR
2024-02-274RayzeBio, Inc. (RYZB)Disposition to issuer (D): 73,731 (derivative) · Disposition to issuer (D): 40,848 (derivative)EDGAR
2024-02-024ENZO BIOCHEM INC (ENZ)Grant/award (A): 79,365 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1323304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →